PROFUND ADVISORS LLC

Position in ALT — Altimmune, Inc.

CIK 1129919 BETHESDA, MD

Position in ALT

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$345,337

+$27,663 QoQ

Shares Held

113,598

+10.1% QoQ

Ownership

0.058%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#73

of 210 holders

Holding Since

Mar 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PROFUND ADVISORS LLC holds $165,155,882 across 170 Biotechnology names. ALT ranks #124 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	23,398	$11,622,488
2	REGN	Regeneron Pharmaceuticals, Inc.	10,444	$6,512,251
3	ALNY	Alnylam Pharmaceuticals, Inc.	13,814	$4,158,428
4	MRNA	Moderna, Inc.	33,142	$2,320,934
5	APGE	Apogee Therapeutics, Inc.	17,163	$2,278,044
6	CYTK	Cytokinetics Inc	25,572	$2,178,478
7	TWST	Twist Bioscience Corp	21,095	$2,170,253
8	KRYS	Krystal Biotech, Inc.	5,770	$2,144,535

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$345,337	113,598	+10.1%	Shares	Sole	2026-08-11
2026-03-31	$317,674	103,141	+42.7%	Shares	Sole	2026-04-27
2025-12-31	$260,995	72,298	+114.5%	Shares	Sole	2026-02-06
2025-09-30	$127,094	33,712	+55.3%	Shares	Sole	2025-11-06
2025-06-30	$84,029	21,713	-27.0%	Shares	Sole	2025-08-07
2025-03-31	$148,795	29,759	-2.6%	Shares	Sole	2025-05-08
2024-12-31	$220,265	30,550	-1.3%	Shares	Sole	2025-02-14
2024-09-30	$190,057	30,954	-24.1%	Shares	Sole	2024-11-14
2024-06-30	$271,060	40,761	-69.8%	Shares	Sole	2024-08-13
2024-03-31	$1,372,691	134,842	+43.6%	Shares	Sole	2024-05-08
2023-03-31	$396,338	93,919	—	Shares	Sole	2023-05-12
No filing history on record for this holder in this stock.